ReviewDigital health
Digital health technologies for monitoring and managing IBD-related fatigue: A scoping review.
Review in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fatigue is a common, persistent symptom in inflammatory bowel disease (IBD). Digital health technologies (DHTs) may enable ongoing monitoring and timely support, yet the relevant evidence remains dispersed. Objective: To map how DHTs are used to monitor or manage IBD-related fatigue, summarize intervention characteristics, measures, feasibility, acceptability, and reported effectiveness. Methods: Following the Joanna Briggs Institute (JBI) methodology and the Arksey O' Malley framework, and reported per PRISMA extension for Scoping Reviews (PRISMA-ScR), eight databases and gray sources from inception to 30 October 2025 were searched using a Population-Concept-Context schema. Eligible studies used a DHT to assess or manage IBD-related fatigue. Screening and data charting were conducted in duplicate; findings were synthesized narratively. Results: Eleven studies were included: four randomized trials, two cohorts, one program evaluation, one non-randomized feasibility study, one multisensor pilot, one mixed-methods study, and one qualitative study. Technologies fell into six groups: telemedicine portals, web-based cognitive behavioral therapy (CBT) self-management, mobile self-management applications, device-linked neuromodulation, wearable-enabled monitoring, and eDiary-based symptom tracking. Feasibility and acceptability were commonly reported in patient-facing studies, and implementation-focused evidence suggested professional acceptability when roles and workflows were clearly defined. Randomized comparisons rarely showed significant differences in fatigue improvement between the groups. Patient-reported outcomes predominated, including IBD-F, FACIT-F, FSS, and PROMIS-Fatigue. Device metrics were mainly activity-based with limited higher-frequency physiology. Engagement often declined, and misalignment between measurement and intervention design was common. Conclusions: Current evidence suggests that DHTs for IBD-related fatigue are generally feasible and acceptable in the studied contexts, but evidence for reducing fatigue is limited and mixed. A pragmatic next step may be a hybrid measurement strategy combining validated fatigue questionnaires, brief daily ratings, and a small set of interpretable device metrics within timing-sensitive trial designs to support implementation in routine care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.